Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13526458 | 0.80 | CYP2D6 (0.36) | CYP2D6CYP2C19 | |
| SCHEMBL4270319 | 0.79 | CYP2D6 (0.36) | CYP2D6CYP2C19TP53 | |
| SCHEMBL14590445 | 0.78 | CYP2D6 (0.33) | CYP2D6CYP2C19 | |
| SCHEMBL14531157 | 0.77 | CYP2D6 (0.35) | CYP2D6CYP2C19 | |
| SCHEMBL5837137 | 0.77 | CYP2D6 (0.35) | CYP2D6CYP2C19 | |
| SCHEMBL5836559 | 0.77 | CYP2D6 (0.35) | CYP2D6CYP2C19 | |
| SCHEMBL5836976 | 0.73 | CYP2D6 (0.35) | CYP2D6CYP2C19 | |
| SCHEMBL13525792 | 0.72 | CYP2D6 (0.35) | CYP2D6CYP2C19 | |
| SCHEMBL13525839 | 0.72 | CYP2D6 (0.47) | CYP2D6CYP2C19 | |
| SCHEMBL5838301 | 0.72 | SMN1; SMN2 (0.32) | CYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7649118-B2 | Process for preparing fluorine-containing norbornene derivative | DAIKIN INDUSTRIES, LTD. (JP) | 2010-01-19 | — | — | US | disclosed |
| US-20070129576-A1 | Process for preparing fluorine-containing norbornene derivative | DAIKIN INDUSTRIES, LTD. | 2007-06-07 | — | — | US | disclosed |
| US-7186773-B2 | Process for preparing fluorine-containing norbornene derivative | DAIKIN INDUSTRIES, LTD. (JP) | 2007-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070129576-A1 | Process for preparing fluorine-containing norbornene derivative | ADH1A, FLNA, FFAR2 | CYP2D6 1459/4885CYP2C19 1106/4885NR1H2 1336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.